Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

IllumiNeuro Protocol Overview, Dosing & Safety | Peptide Database

IllumiNeuro Protocol (IllumiNeuro) Four-Peptide Cognitive Enhancement Blend Community Research Join others researching IllumiNeuro Protocol — share findings, ask questions, and learn from real experiences IllumiNeuro is a cognitive enhancement peptide blend co

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

IllumiNeuro Protocol (IllumiNeuro)

Four-Peptide Cognitive Enhancement Blend

Community Research

Join others researching IllumiNeuro Protocol — share findings, ask questions, and learn from real experiences

IllumiNeuro is a cognitive enhancement peptide blend combining four nootropic peptides: PE-22-28 (neuritogenic), Pinealon (pineal bioregulator), NA-Semax Amidate (neuroprotective/cognitive), and NA-Selank Amidate (anxiolytic/cognitive). The standard formulation contains 48mg total (PE-22-28 10mg + Pinealon 10mg + NA-Semax 20mg + NA-Selank 8mg). This blend targets multiple neurological pathways for comprehensive cognitive support, though no clinical studies exist on this specific four-peptide combination.

Each peptide contributes distinct neurological mechanisms: PE-22-28 promotes neurite outgrowth and neural connectivity through sphingosine-1-phosphate receptor modulation; Pinealon is a bioregulator that supports pineal gland function and circadian regulation; NA-Semax Amidate provides BDNF upregulation and neuroprotection; NA-Selank Amidate offers anxiolytic effects through GABA modulation and immune-neuroendocrine regulation. Together, they theoretically address cognitive enhancement, neuroprotection, mood support, and neural regeneration.

Molecular Data

Complex or non-standard sequence format

Research Indications

Combined BDNF support and neuritogenic effects may enhance memory formation and learning.

NA-Semax component supports sustained attention and mental clarity.

Multiple pathways protecting neural tissue from oxidative stress and damage.

NA-Selank provides anxiolytic effects through GABA modulation.

Immune-neuroendocrine support helps with stress resilience.

Combined effects on neurotransmitter systems may improve overall mood.

PE-22-28 promotes neural connectivity and neurite extension.

Pinealon supports healthy sleep-wake cycles and pineal function.

Dosing Protocols

Subcutaneous injection is the standard delivery method. Some users also administer intranasally for more direct CNS effects. Amidate forms (NA-Semax and NA-Selank) have enhanced stability and duration.

Conservative cognitive support

100-200mcg total blend

Once daily (morning)

SubQ or intranasal

Standard protocol

200-400mcg total blend

Once daily

SubQ

Enhanced protocol

400-500mcg total blend

Reconstitution Instructions

IllumiNeuro 48mg vial

Bacteriostatic water (2-4mL)

Insulin syringes

Alcohol prep pads

1 Clean vial top with alcohol pad

2 Add 2mL bacteriostatic water (creates 24mg/mL)

3 Gently swirl - do not shake

4 Solution should appear clear

5 Label with date and concentration

6 Store refrigerated immediately

7 Use within 4 weeks

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Injection site reactions (mild)

Nasal irritation if used intranasally

Possible vivid dreams (Pinealon effect)

Mild headache initially

Stop Signs - Discontinue if:

Severe headaches

Significant mood changes

Allergic reactions

Cognitive impairment instead of enhancement

Contraindications

No clinical trials on four-peptide combination

Bipolar disorder or psychosis (caution with cognitive enhancers)

Pregnancy or breastfeeding

Seizure disorders (theoretical concern)

Quality Checklist

Good Signs

Third-party testing confirming all four components

Certificate of Analysis with ratios verified

Reputable research supplier

Proper cold chain shipping

Warning Signs

Research-only status - not approved for human use

Complex four-peptide formulation may have batch variability

Bad Signs

No Certificate of Analysis

Cannot verify component ratios

Suspiciously low pricing

Frequently Asked Questions

What's in IllumiNeuro and why is it a blend?

IllumiNeuro combines four neuroactive peptides: PE-22-28 (neurite growth), Pinealon (pineal/circadian support), NA-Semax (BDNF/neuroprotection), and NA-Selank (anxiety relief). The blend targets multiple cognitive pathways simultaneously for theoretically broader benefits than any single peptide.

Can I take IllumiNeuro separately or must I use the blend?

You can take individual components separately, but do NOT add extra NA-Semax or NA-Selank to the blend—they're already included. The standard 48mg vial contains all four at fixed ratios: PE-22-28 10mg, Pinealon 10mg, NA-Semax 20mg, NA-Selank 8mg.

Does IllumiNeuro work for anxiety specifically?

The NA-Selank component has documented anxiolytic effects via GABA modulation. However, no clinical studies exist on this four-peptide combination. Individual peptides show promise for anxiety in research, but human efficacy data is limited.

Should I inject IllumiNeuro in the morning or evening?

Morning dosing is preferred for cognitive benefits during the day. Pinealon's sleep-supporting properties might suggest evening, but most users report better focus and mental clarity when dosed in the morning on an empty stomach.

References

PE-22-28 promotes neurite outgrowth through S1P receptor modulation.

Enhanced stability amidate form of Semax with BDNF upregulation and neuroprotective effects.

Selank demonstrates anxiolytic effects through GABA modulation and immune-neuroendocrine regulation.

Pinealon (EDR tripeptide) supports pineal gland function and circadian regulation.

Related Peptides

Complementary pineal/longevity support; different mechanisms.

Different targets; BPC-157 may complement with healing/gut-brain effects.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

FDA-approved for postmenopausal women with osteoporosis at high risk for fracture or who have failed other therapies. FDA-approved for men with osteoporosis at high risk for fracture or intolerant to other treatments. Phase III trials demonstrated substantial reduction in vertebral and nonvertebral fractures. ACTIVExtend trial showed benefits of abaloparatide followed by alendronate for maintained bone protection.

Source: peptide-db.com ↗

Community Research

Join others researching Vilon — share findings, ask questions, and learn from real experiences Vilon is a Khavinson bioregulator dipeptide (KE) consisting of lysine and glutamic acid, originally isolated from thymus gland extracts. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it acts as a molecular signaling compound that restores normal gene expression and protein synthesis in immune and epithelial cells. Research shows Vilon increases mean lifespan by 20-40% in animal studies and suppresses tumor development. Vilon works through epigenetic modulation, restoring chromatin structure and gene expression in immune cells. It stimulates thymocyte proliferation, activates T-helper cells, and increases the proliferative index in thymus tissue (from 26% to 37% in studies). The peptide modulates tyrosine phosphorylation of mitogen-activated cytoplasmic kinases and helps rejuvenate aged immune systems by restoring proper gene expression patterns.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Primary administration route with well-established protocols for direct brain delivery via IV/IM. Small Volume IV Up to 10mL Once daily Undiluted IV slow push over 3 minutes Intramuscular Up to 5mL Undiluted IM injection over 3 minutes Acute Stroke 20-50mL Once daily for 10-21 days IV infusion (diluted to 100mL minimum) Traumatic Brain Injury Once daily for 7-30 days Alzheimer's Disease 10-30mL 5 days weekly for 4 weeks IV injection/infusion (2-4 cycles yearly) Vascular Dementia

Source: peptide-db.com ↗
Side effects

Common Side Effects

Hot flashes and night sweats Nausea or gastrointestinal discomfort Mood swings, irritability, or emotional lability Fatigue during initial weeks of use Headache

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →